Search Within

Advanced Practice Providers

Formats
  1. Meeting Abstract (754)
  2. Journal Article (589)
  3. Review (56)
  4. Book Section (39)
  5. Editorial (18)
  6. Research Letter (15)
  7. Miscellaneous (11)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Nursing (1172)
  2. Department of Medicine (704)
  3. Survivorship Research (530)
  4. Center for Hematologic Malignancies (363)
  5. Solid Tumor Oncology Division (350)
  6. Hematologic Malignancies, Division of (349)

More Groups

People
  1. Sergio Giralt (103)
  2. Miguel-Angel Perales (84)
  3. Gunjan Shah (73)
  4. Sean Devlin (71)
  5. Maria Palomba (69)
  6. Craig Sauter (63)

More People

Years
  1. 2026 (1)
  2. 2025 (78)
  3. 2024 (128)
  4. 2023 (97)
  5. 2022 (119)
  6. 2021 (108)

More Years

Publications
  1. Journal of Clinical Oncology (179)
  2. Oncology Nursing Forum (133)
  3. Blood (123)
  4. Biology of Blood and Marrow Transplantation (61)
  5. Clinical Journal of Oncology Nursing (50)
  6. Annals of Surgical Oncology (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (202)
  2. Elsevier Inc. (200)
  3. Oncology Nursing Society (ONS) (188)
  4. American Society of Hematology (131)
  5. Lippincott Williams & Wilkins (103)
  6. Springer (72)

More Publishers

Results (1492)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Top ten tips palliative care clinicians should know about addressing patient sexuality and intimacy in serious illness
    Editorial

    Chammas, D.; Shindel, A. W.; Rowen, T. S.; Schanche, K.; Wittmann, D.; Shalev, D.; Addario, J. D.; Wisniewski, R.; Scheel, T.; Nelson, C. J.; more...
    Journal of Palliative Medicine (2024)

    Fulltext@MSK | Save
  • Why so blue? Serotonin syndrome in dapsone-induced methemoglobinemia
    Meeting Abstract

    Kuhnly, N.; Zhu, A.; Chen, L.; Dulu, A.
    Critical Care Medicine (2024)

    Fulltext@MSK | Save
  • Car T-associated bacteremia: A single-center, five-year retrospective
    Meeting Abstract

    Fowler, C.; Tayban, Y.; Mead, E.
    Critical Care Medicine (2024)

    Fulltext@MSK | Save
  • High-flow oxygen therapy via tracheostomy to wean from prolonged mechanical ventilation
    Meeting Abstract

    Nwogugu, S.; Pastores, S.
    Critical Care Medicine (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD)-adapted duration of front-line venetoclax and obinutuzumab treatment for fit patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Mato, A. R.; Zelenetz, A. D.; Park, J. H.; Geyer, M. B.; Derkach, A.; Nemirovsky, D.; Islam, P.; Falchi, L.; Palomba, M. L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save